Micell Technologies has received an investment of $15 million from St. Jude Medical. The investment will enable Micell to explore other medical applications of its stent-coating technology.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan